Trial · NCT02119676
Participant flow16
How many started, completed or left each group, period by period.
1 to 16 of 16
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Substudy 1: Ruxolitinib + Regorafenib | 87 | |
| Overall Study | STARTED | Substudy 1: Placebo + Regorafenib | 88 | |
| Overall Study | STARTED | Substudy 2: Ruxolitinib + Regorafenib | 110 | |
| Overall Study | STARTED | Substudy 2: Placebo + Regorafenib | 111 | |
| Overall Study | Treated Patients | Substudy 1: Ruxolitinib + Regorafenib | 85 | |
| Overall Study | Treated Patients | Substudy 1: Placebo + Regorafenib | 86 | |
| Overall Study | Treated Patients | Substudy 2: Ruxolitinib + Regorafenib | 106 | |
| Overall Study | Treated Patients | Substudy 2: Placebo + Regorafenib | 106 | |
| Overall Study | COMPLETED | Substudy 1: Ruxolitinib + Regorafenib | 4 | |
| Overall Study | COMPLETED | Substudy 1: Placebo + Regorafenib | 2 | |
| Overall Study | COMPLETED | Substudy 2: Ruxolitinib + Regorafenib | 13 | |
| Overall Study | COMPLETED | Substudy 2: Placebo + Regorafenib | 10 | |
| Overall Study | NOT COMPLETED | Substudy 1: Ruxolitinib + Regorafenib | 83 | |
| Overall Study | NOT COMPLETED | Substudy 1: Placebo + Regorafenib | 86 | |
| Overall Study | NOT COMPLETED | Substudy 2: Ruxolitinib + Regorafenib | 97 | |
| Overall Study | NOT COMPLETED | Substudy 2: Placebo + Regorafenib | 101 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02119676/flow